Youngjoo Kwon

Professor

Ewha Womans University

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Cancer Biology Cancer Biology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Youngjoo Kwon is a Professor at Ewha Womans University in South Korea. His research areas include the identification of potential therapeutic agents for kidney fibrosis, tumor angiogenesis, and cancer treatment, with a focus on topoisomerase inhibitors and their interactions. He has published extensively on topics ranging from the design and synthesis of novel compounds to the pathophysiological features of various cancers.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Shamrat Kumar Paul

Clemson University

UNITED STATES

View details

Lee Yun-Sil

Ewha Womans University

SOUTH KOREA

View details

Jae-Kyung Jung

Professor

Chungbuk National University College of Pharmacy

SOUTH KOREA

View details

Takashi Morii

教授 / Professor

Kyoto University

JAPAN

View details

Tara Man Kadayat, PhD, MS, BPharm, GCCTL

Assistant Professor

Larkin University

UNITED STATES

View details

Soonsil Hyun

Chungbuk National University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Youngjoo Kwon

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGFβR-1

Design, Synthesis, and Cytotoxicity and Topoisomerase I/IIα Inhibition Activity of Pyrazolo[4,3-<i>f</i>]quinoline Derivatives

Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R

Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors

Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships

Topologically-Interlocked Minicircles as Probes of DNA Topology and DNA-Protein Interactions

AK-I-190, a New Catalytic Inhibitor of Topoisomerase II with Anti-Proliferative and Pro-Apoptotic Activity on Androgen-Negative Prostate Cancer Cells

Identification of Indicators for Preterm Birth Using Retinoid Metabolites

An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma

Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers

Collaborators (6)

Shamrat Kumar Paul

Lee Yun-Sil

Jae-Kyung Jung

Takashi Morii

Tara Man Kadayat, PhD, MS, BPharm, GCCTL

Soonsil Hyun

Make your next move.

Youngjoo Kwon

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGFβR-1

Design, Synthesis, and Cytotoxicity and Topoisomerase I/II&alpha; Inhibition Activity of Pyrazolo[4,3-<i>f</i>]quinoline Derivatives

Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R

Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors

Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships

Topologically-Interlocked Minicircles as Probes of DNA Topology and DNA-Protein Interactions

AK-I-190, a New Catalytic Inhibitor of Topoisomerase II with Anti-Proliferative and Pro-Apoptotic Activity on Androgen-Negative Prostate Cancer Cells

Identification of Indicators for Preterm Birth Using Retinoid Metabolites

An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma

Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers

Collaborators (6)

Shamrat Kumar Paul

Lee Yun-Sil

Jae-Kyung Jung

Takashi Morii

Tara Man Kadayat, PhD, MS, BPharm, GCCTL

Soonsil Hyun

Make your next move.

Design, Synthesis, and Cytotoxicity and Topoisomerase I/IIα Inhibition Activity of Pyrazolo[4,3-<i>f</i>]quinoline Derivatives